HealthExec February 6, 2020
Amy Baxter

CMS has issued a proposed rule affecting Medicare Advantages and Medicare Part D prescription drug plans.

The agency aims to increase transparency, bring down drug costs for seniors through cost sharing changes, and bring other benefit flexibilities to MA plans. It also issued Part II of the 2021 Advance Notice for MA rates and Part D payment policies on Feb. 5. The agency expects $4.4 billion in savings to the government over a decade through the proposed changes.

According to CMS, the changes aim to lower beneficiary cost sharing and will let some beneficiaries know their out-of-pocket costs in advance for comparisons for different prescription drugs. Medicare Advantage plans will see a 0.93% plan revenue increase in 2021 under the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Patient / Consumer, Pharma, Pricing / Spending, Provider
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year
Walmart To Expand Same-Day Prescription Delivery Nationwide
Podcast: Market Failures, Lessons or Opportunities? 1/30/25
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps: 5 notes

Share This Article